Poster: Methodology - New Modelling Approaches

Post-hoc model joining with Normalizing Flows for efficient and scalable multi-endpoint PKPD

Thursday 7 May, 2026

Objectives Utilizing longitudinal biomarkers to improve primary endpoint predictions is a common objective in clinical pharmacology, yet traditional joint NLME…

Read more

A STRUCTURED APPROACH TO PHARMACOMETRIC COVARIATE MODELING: WHY THE ESTIMAND IS THE FIRST DECISION AND THE METHOD THE SECOND

Thursday 7 May, 2026

Objectives Covariates in pharmacometric models have two important objectives[1]. First, they support mechanistic understanding by helping to identify the physiological…

Read more

AN ASYMPTOTIC THEORY ON THE COMPETITIVE BINDING OF THERAPEUTIC AND ENDOGENOUS ANTIBODIES TO FCRN

Thursday 7 May, 2026

Introduction: Over the last few decades physiology-based pharmacokinetic (PBPK) models have received increasingly more attention not just as an academic…

Read more

A QUANTITATIVE SYSTEMS PHARMACOLOGY (QSP) MODEL LINKING KIT SIGNALING TO MAST CELL DEGRANULATION AND DEPLETION

Thursday 7 May, 2026

Objective: Mast cells (MCs) serve an important role in inflammatory and allergic reactions. KIT, a receptor tyrosine kinase, regulates MC…

Read more

Towards an Inflammation Simulation Model: Development and Validation of a Mathematical Model of the Human Inflammatory Response to Acute and Prolonged Lipopolysaccharide Exposure

Thursday 16 October, 2025

Introduction: Cytokines are inflammatory mediators that play a pivotal role in the initiation and orchestration of the immune response [1]. IL-6,…

Read more

Integrating PKPD and Agent-Based Modeling to Explore Tuberculosis Relapse after Treatment.

Thursday 16 October, 2025

Introductions: The immune system’s significance in Tuberculosis (TB) drug development is often underestimated due to experimental complexities. In this study,…

Read more

A Neural Networks-assisted NLME Framework: Case Study on Modeling Platelet Counts

Thursday 16 October, 2025

Objectives: Thrombocytopenia, a frequent adverse event type in cancer therapy, requires clinical platelet management to avoid high-grade thrombocytopenia and to…

Read more

Supporting pharmacometrics applications by robust parameter estimation and identifiability analysis using hybrid Neural ODEs

Thursday 16 October, 2025

Introduction: Neural Ordinary Differential Equations (NODEs) [1,2] constitute a promising data-driven method for modeling dynamical systems in computational biology. Recent works…

Read more

Using machine learning to predict longitudinal platelet counts: a methodology framework

Thursday 16 October, 2025

Introduction: Conventional exposure-response (ER) models have been employed to model the dynamics of platelet changes during patient treatment, providing insights…

Read more

Addressing Confounding Bias in Exposure-Response Analysis: Evaluating Instrumental Variable Modeling Strategies

Thursday 16 October, 2025

Objectives:  Randomization of subjects to multiple dose levels in clinical trials enables an unbiased estimation of the dose-response relationship. However,…

Read more